Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$254.9 - $283.59 $2,294 - $2,552
9 Added 1.08%
841 $217,000
Q1 2023

May 02, 2023

SELL
$229.71 - $259.35 $16,998 - $19,191
-74 Reduced 8.17%
832 $205,000
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $197,770 - $232,760
906 New
906 $230,000
Q2 2019

Aug 14, 2019

SELL
$217.4 - $246.08 $260,880 - $295,296
-1,200 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$206.05 - $248.17 $16,484 - $19,853
-80 Reduced 6.25%
1,200 $300,000
Q4 2018

Feb 14, 2019

SELL
$204.73 - $257.93 $28,866 - $36,368
-141 Reduced 9.92%
1,280 $281,000
Q3 2018

Nov 14, 2018

SELL
$233.07 - $256.0 $104,881 - $115,200
-450 Reduced 24.05%
1,421 $0
Q2 2018

Aug 08, 2018

SELL
$208.1 - $233.85 $83,240 - $93,540
-400 Reduced 17.61%
1,871 $0
Q1 2018

May 11, 2018

BUY
$205.46 - $240.27 $124,508 - $145,603
606 Added 36.4%
2,271 $0
Q3 2017

Nov 03, 2017

BUY
$186.89 - $198.9 $311,171 - $331,168
1,665
1,665 $326,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $63.3B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Maple Capital Management, Inc. Portfolio

Follow Maple Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maple Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Maple Capital Management, Inc. with notifications on news.